INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
BP

Burnett Patrick

EVP, Chief Medical OfficerCIK 0001741987

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 7
Max Insider Score26
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
BP
Burnett PatrickEVP, Chief Medical Officer
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$30K
943 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Arcutis Biotherapeutics, Inc.See Remarks · Nov 5, 2025
9
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M
—
6,700 sh
Aug 12, 2026
Aug 13, 2026
traded Aug 12, 2026
+1d
SEC FORM 4

Evidence

9
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M$30K
8,300 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

24
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$220K
8,300 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

9
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M$24K
6,700 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

24
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$175K
6,700 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

9
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M—
8,300 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

2
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
17.3K sh
Nov 6, 2025Nov 10, 2025
traded Nov 6, 2025
+4dSEC FORM 4

Evidence

26
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$417K
17.3K sh
Nov 6, 2025Nov 10, 2025
traded Nov 6, 2025
+4dSEC FORM 4

Evidence

0
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Option exercise · 10b5-1 plan
M—
17.3K sh
Nov 6, 2025Nov 10, 2025
traded Nov 6, 2025
+4dSEC FORM 4

Evidence

23
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
2,607 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

20
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$381
15 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC FORM 4

Evidence

19
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
3,864 sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC FORM 4

Evidence